Effects of nasal continuous positive airway pressure treatment on C-reactive protein in patients with obstructive sleep apnea

I. Bouloukaki, N. Tzanakis, T. Eleni, M. Violeta, M. Eleni, N. Siafakas, S. Schiza (Heraklion, Greece)

Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing
Session: Systemic consequences of sleep-disordered breathing
Session type: E-Communication Session
Number: 2846
Disease area: Sleep and breathing disorders

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Bouloukaki, N. Tzanakis, T. Eleni, M. Violeta, M. Eleni, N. Siafakas, S. Schiza (Heraklion, Greece). Effects of nasal continuous positive airway pressure treatment on C-reactive protein in patients with obstructive sleep apnea. Eur Respir J 2009; 34: Suppl. 53, 2846

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of continuous positive airway pressure treatment on elevated levels of C-reactive protein in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 330s
Year: 2004

Continuous positive airway pressure in patients with obstructive sleep apnea: Age-dependent adherence
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010


Effect of continuous positive airway pressure treatment on hypoadiponectinemia in male patients with obstructive sleep apnea syndrome
Source: Annual Congress 2005 - Metabolic control in OSA
Year: 2005


Titration of continuous positive airway pressure in Chinese patients with obstructive sleep apnea
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012


Evaluation of continuous positive airway pressure compliance in a group of obstructive sleep apnea patients
Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology
Year: 2012

Treatment of obstructive sleep apnoea with nasal continuous positive airway pressure in stroke
Source: Eur Respir J 2001; 18: 623-629
Year: 2001



Liver function following continuous positive airway pressure therapy in obstructive sleep apnea patients
Source: International Congress 2017 – CPAP therapy
Year: 2017


Nasal continuous positive airway pressure treatment improves elevated soluble CD40 ligand in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 331s
Year: 2004

Bronchial reactivity in patients with obstructive sleep apnea syndrome treated with continuous positive airway pressure
Source: Eur Respir J 2005; 26: Suppl. 49, 569s
Year: 2005

Angiogenic factors in obstructive sleep apnea syndrome (OSA). Effects of nasal continuous positive airway pressure treatment (CPAP)
Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea
Year: 2010


Index for comfort of patients with obstructive sleep apnea on continuous positive airway pressure therapy
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008

Exhaled breath markers in patients with obstructive sleep apnea (OSA): baseline assessment and the impact of treatment with nasal continuous positive airway pressure
Source: Eur Respir J 2005; 26: Suppl. 49, 355s
Year: 2005

Erratic adherence to continuous positive airway pressure for obstructive sleep apnea
Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS)
Year: 2018

Humidified nasal continuous positive airway pressure in obstructive sleep apnoea
Source: Eur Respir J 2003; 22: 258-262
Year: 2003



Evaluation of long-term effect of continuous positive airway pressure (CPAP) therapy on reduction of high sensitivity C-reactive protein (HSCRP) for patients with obstructive sleep apnea syndrome (OSAS)
Source: Eur Respir J 2005; 26: Suppl. 49, 357s
Year: 2005

Falls in blood pressure in patients with obstructive sleep apnea syndrome after long-term nasal continuous positive airway pressure treatment
Source: Eur Respir J 2005; 26: Suppl. 49, 38s
Year: 2005

Optimal positive airway pressure predicts oral appliance response to obstructive sleep apnoea
Source: Annual Congress 2010 - The upper airway and oral appliances
Year: 2010


Nocturnal melatonin plasma levels in patients with OSAS: the effect of CPAP
Source: Eur Respir J 2007; 30: 496-500
Year: 2007



Predictors of continuous positive airway pressure adherence in obstructive sleep apnea syndrome
Source: International Congress 2017 – Inhalers and their use
Year: 2017


The influence of 3-weeks‘ therapy of continous positive airway pressure (CPAP) on serum leptin and homocysteine concentration in patients with obstructive sleep apnea (OSA)
Source: Annual Congress 2005 - Metabolic control in OSA
Year: 2005